AbCellera Biologics Inc. ABCL Grants And Incentives
Grants And Incentives at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept abcl:GrantsAndIncentives.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s grants and incentives.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s grants and incentives?
- AbCellera Biologics Inc. (ABCL) reported grants and incentives of $4.34M in Q1 2026.
- How has AbCellera Biologics Inc.'s grants and incentives changed year-over-year?
- AbCellera Biologics Inc.'s grants and incentives increased by 4.5% year-over-year, from $4.15M to $4.34M.
- What is the long-term trend for AbCellera Biologics Inc.'s grants and incentives?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s grants and incentives has grown at a -5.6% compound annual growth rate (CAGR), from $17.49M to $13.89M.
- What does grants and incentives mean?
- This captures non-dilutive funding or financial support received from government bodies or research organizations to subsidize specific development activities. It serves as a critical indicator of external validation for the company's research pipeline and helps offset operational burn. Higher levels of this income reduce the reliance on equity financing for R&D projects.